Microparticles based on natural and synthetic polymers for ophthalmic applications
Source abstract
Abstract
Abstract Sodium salt of carboxymethylcellulose/poly(vinyl alcohol) particles suitable for application in ocular drug administration were prepared by crosslinking with epichlorohydrin in an alkaline medium, in reverse emulsion. The influence of parameters related with the particles elaboration process (ratio between polymer mixture and crosslinking agent, concentration of polymer solution, duration of crosslinking reaction, stirring intensity, etc.) based on their composition, size, and swelling ability was studied. Obtained microparticles fulfill the requirements for biomaterials—they are formed from biocompatible polymers; the acute toxicity value (LD50) is high enough to consider these materials as weakly toxic (hence able to introduce within the organism); they are able to include and release drugs in a controlled way. The in vivo adrenalin ocular delivery from the microparticles was tested on voluntary human patient. The particles showed good adhesion properties without irritation to the patient and proved the capability to treat the ocular congestion. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2012.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Ocular Surface and Contact Lens · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Importance of the noncorneol absorption route in topical ophthalmic drug delivery
2. 10.1016/j.addr.2005.07.00510.1016/j.addr.2005.07.005 ↗
3. Kreuter J · 1993 · 275
4. Robinson JC · 1993 · 29
5. CohenEM GrimWM HarwoodRJ MehtaGN. Solid state ophthalmic medication. U.S. Pat. 4 179597 (1979).
6. Jain NK · 2005 · 110
7. 10.1089/jop.1986.2.6710.1089/jop.1986.2.67 ↗
8. Novel approaches to ocular drug delivery
9. Modern delivery systems for ocular drug formulations: A comparative overview w.r.t conventional dosage form
10. 10.1615/CritRevTherDrugCarrierSyst.v26.i1.1010.1615/CritRevTherDrugCarrierSyst.v26.i1.10 ↗
11. 10.1023/B:PHAM.0000045239.22049.7010.1023/B:PHAM.0000045239.22049.70 ↗
12. 10.2174/138945005376591410.2174/1389450053765914 ↗
13. Kreuter J · 1994 · 165
14. Evaluation of nanoparticles as drug delivery systems I: Preparation methods
15. 10.1111/j.2042-7158.1997.tb06103.x10.1111/j.2042-7158.1997.tb06103.x ↗
16. 10.1016/j.carbpol.2007.12.01210.1016/j.carbpol.2007.12.012 ↗
17. Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: In vitro and in vivo release studies
18. 10.1111/j.2042-7158.1995.tb06718.x10.1111/j.2042-7158.1995.tb06718.x ↗
19. 10.1016/j.carbpol.2006.01.01310.1016/j.carbpol.2006.01.013 ↗
20. 10.1002/app.2720310.1002/app.27203 ↗
21. 10.1365/s10337-004-0231-y10.1365/s10337-004-0231-y ↗
22. 10.1002/pi.250210.1002/pi.2502 ↗
23. 10.1167/iovs.10-646510.1167/iovs.10-6465 ↗
24. Hydrogels based on carboxymethylcellulose and poly (vinyl alcohol) for controlled loading and release of chloramphenicol
25. 10.1016/j.colsurfa.2007.08.04010.1016/j.colsurfa.2007.08.040 ↗
26. Finney DJ · 1978 · 394
27. Acute toxic effects of trimethyl and triethyl phosphates
28. 10.1002/jps.260052121010.1002/jps.2600521210 ↗
29. 10.1016/j.foodhyd.2007.10.00110.1016/j.foodhyd.2007.10.001 ↗
30. Meyers RA · 2000 · 10815
31. 10.1016/j.msec.2004.08.04610.1016/j.msec.2004.08.046 ↗
32. 10.1016/S0142-9612(02)00378-210.1016/S0142-9612(02)00378-2 ↗
33. DesbrieresJ PopaM Maftei (Tataru)G.Systemes Polymeres Sous Forme de Particules Editions Universitaires Européennes. Germany: Südwestdeutscher Verlag für Hochschulschriften GmbH and Co.;2010.
34. Ein Universal puffer fur den pH‐Bereich 2.0 bis 12.0
35. 10.1021/bm010147y10.1021/bm010147y ↗